عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
شماره کتابشناسی ملی
شماره
TLpq2404679938
زبان اثر
زبان متن نوشتاري يا گفتاري و مانند آن
انگلیسی
عنوان و نام پديدآور
عنوان اصلي
Supplementation of Omega-3 Fatty Acid in Women During Pregnancy:
نام عام مواد
[Thesis]
نام نخستين پديدآور
Su, Jessica
عنوان اصلي به قلم نويسنده ديگر
An Approach that Can Potentially Reduce the Risk of Developing Postpartum Depression
نام ساير پديدآوران
Gordon-Elliott, Janna
وضعیت نشر و پخش و غیره
نام ناشر، پخش کننده و غيره
Weill Medical College of Cornell University
تاریخ نشرو بخش و غیره
2020
مشخصات ظاهری
نام خاص و کميت اثر
47
یادداشتهای مربوط به پایان نامه ها
جزئيات پايان نامه و نوع درجه آن
M.S.
کسي که مدرک را اعطا کرده
Weill Medical College of Cornell University
امتياز متن
2020
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Problem: Postpartum depression (PPD) is one of the most common complications of childbirth and is a concerning major public health issue. PPD is associated with numerous adverse outcomes of the women and also the offspring and the family. If left untreated, PPD can affect the mental health of the women and also the development of the offspring. Purpose: The goal of this study is to investigate if supplementing omega-3 fatty acid to pregnant women during pregnancy can reduce the risk of developing PPD. Research Questions: Does supplementation of omega-3 fatty acid to women during pregnancy help reduce the risk of developing PPD? Methods: A randomized, double-blinded, placebo controlled clinical trial is proposed. Women who are between the ages of 18-45, in less than 12 weeks of gestation of a singleton pregnancy, with no other births in the previous two years, no chronic diseases or other psychiatric history, no current or history of major depressive disorder (MDD) and PPD, no family history of PPD, and no current substance abuse will be eligible for this study. Women who are taking antidepressants and/ or omega-3 fatty acid supplements, receiving psychotherapy, and who have a PHQ-9 score of five and above at baseline during screening will be excluded from the study. Research subjects will be recruited from Women, Infant, and Children (WIC) offices in the New York metropolitan area that are affiliated with New York Presbyterian Hospitals. Participants will be randomly assigned to 2 groups that will receive: 1) omega-3 FAs supplements containing a total of 830 mg omega-3 FAs that includes DHA/EPA (480 mg/205 mg) or 2) placebo (corn oil) from 14 weeks of gestation until 24 weeks after childbirth. Serum n-3 levels will be sampled and analyzed every 12 weeks. Symptoms of depression will be assessed prior to delivery and every 4 weeks after childbirth until 12 months by using a self-report scale- the Patient Health Questionnaire-Nine Item (PHQ-9). Outcomes: Participants will be followed for depression symptoms and possible diagnosis of PPD until 12 months after childbirth Benefit: Supplementation of omega-3 fatty acid to women during early pregnancy and early postpartum period may reduce the risk of developing PPD.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Medicine
موضوع مستند نشده
Nutrition
موضوع مستند نشده
Omega-3 fatty acid
موضوع مستند نشده
Postpartum depression
موضوع مستند نشده
Pregnancy
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )
مستند نام اشخاص تاييد نشده
Gordon-Elliott, Janna
مستند نام اشخاص تاييد نشده
Su, Jessica
دسترسی و محل الکترونیکی
نام الکترونيکي
مطالعه متن کتاب وضعیت انتشار
فرمت انتشار
p
اطلاعات رکورد کتابشناسی
نوع ماده
[Thesis]
کد کاربرگه
276903
اطلاعات دسترسی رکورد
سطح دسترسي
a
تكميل شده
Y
